The current opioid overdose crisis is characterized by the presence of unknown psychoactive adulterants. Xylazine is an alpha-2 receptor agonist that is not approved for human use but is commonly used in veterinary medicine due to its sedative and muscle-relaxant properties. Cases of human intoxication due to accidental or voluntary use have been reported since the 1980s. However, reports of adulteration of illicit opioids (heroin and illicit fentanyl) with xylazine have been increasing all over Western countries. In humans, xylazine causes respiratory depression, bradycardia, and hypotension-posing individuals, using xylazine-adulterated opioids. We present a narrative review of the latest intoxication cases related to xylazine, to bring awareness to readers and also to help pathologists to detect and deal with xylazine cases.

Malaca S., Pesares M., Kapoor A., Berretta P., Busardo F.P., Pirani F. (2023). Pharmacology and toxicology of xylazine: quid novum?. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 27(15), 7337-7345 [10.26355/eurrev_202308_33305].

Pharmacology and toxicology of xylazine: quid novum?

Pirani F.
Ultimo
2023

Abstract

The current opioid overdose crisis is characterized by the presence of unknown psychoactive adulterants. Xylazine is an alpha-2 receptor agonist that is not approved for human use but is commonly used in veterinary medicine due to its sedative and muscle-relaxant properties. Cases of human intoxication due to accidental or voluntary use have been reported since the 1980s. However, reports of adulteration of illicit opioids (heroin and illicit fentanyl) with xylazine have been increasing all over Western countries. In humans, xylazine causes respiratory depression, bradycardia, and hypotension-posing individuals, using xylazine-adulterated opioids. We present a narrative review of the latest intoxication cases related to xylazine, to bring awareness to readers and also to help pathologists to detect and deal with xylazine cases.
2023
Malaca S., Pesares M., Kapoor A., Berretta P., Busardo F.P., Pirani F. (2023). Pharmacology and toxicology of xylazine: quid novum?. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 27(15), 7337-7345 [10.26355/eurrev_202308_33305].
Malaca S.; Pesares M.; Kapoor A.; Berretta P.; Busardo F.P.; Pirani F.
File in questo prodotto:
File Dimensione Formato  
7337-7345.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 827.6 kB
Formato Adobe PDF
827.6 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/955023
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact